Scientifically for serious technical reasons of tumour formation and immune rejection, trials with embryo stem cells are highly unlikely to proceed in humans while adult stem cells are already making dramatic advances in human trials even in Australia. These advances are happening in the areas of spinal injury at the PA Hospital in Brisbane, and heart disease at the John Hunter Institute in Newcastle. In the months ahead advances are expected in Parkinson's disease at the Peter McCallum Institute in Melbourne.